Polymorphonuclear leukocytes (PMN) employ a system comprised of myeloperoxidase (MPO), H20 2, and an oxidizable halide cofactor to kill a variety of microorganisms (for reviews see 1, 2) . After particle ingestion, MPO is released into the phagocytic vacuole and H20 2 is produced in association with the postphagocytic metabolic burst . Both MPO (3, 4) and H202 (5) are also released into the extracellular fluid during phagocytosis . While the intravacuolar role of the MPO system is well established (1, 2), no extracellular biologic activity of this system other than iodination of nonspecific proteins (1, 6) has been demonstrated . The killing of mammalian tumor cells by the peroxidase system employing isolated components has recently been described (7-9) . The current report documents a cytotoxic effect of intact human PMN on neoplastic cells and provides evidence for the involvement of the peroxidase system in mediating this activity .
hold, N. J. MPO prepared from canine PMN by the method of Agner through the end of step six (13) was assayed by the o-dianisidine method (14) ; 1 U utilizes 1 umol of substrate/min at 25°C (15) . Zymosan (Nutritional Biochemical Corp ., Cleveland, Ohio) was homogenized, incubated for 20 min at 37°C in either fresh frozen (-70°C) human AB serum (preopsonized zymosan) or modified Hanks' solution (9) (nonopsonized zymosan), washed, and suspended in water at 10 mg/ml.
Results PMN-Zymosan-Halide Cytotoxicity System . Table I demonstrates the cytotoxic effect of a system comprised of PMN, preopsonized zymosan, and a halide . Significant "Cr release above control (P < 0.001) was observed using either 0.1 M chloride or 10 -4 M iodide as the halide or using a combination of both halides TABLE I PMN-Zymosan-Halide Cytotoxicity System "Cr release
The complete reaction mixture contained 0.03 M sodium phosphate buffer pH 7.0, 1.5 x 10 -' M KH,P0,, 1.5 x 10 -' M MgSO 10 5 LSTRA cells, and the supplements indicated below as follows: PMN, 2.5 x 10 5; zymosan (ZYM), 0.1 mg (preopsonized except as indicated) ; chloride and iodide as the sodium salts in the concentrations indicated; azide and cyanide as the sodium salts at 10-M ; and catalase, 1,400 U. In tubes containing either no NaCl or 4 x 10 -' M NaCl, Na,S0 0.067 M or 0.04 M, respectively, was added to maintain isosmolarity . Total vol was 0.5 ml . PMN or catalase were preheated at 100°C for 15 min where indicated . * Mean t SE (number of experiments) . $ Significantly increased above control, P < 0.001 ; all others NS (t test) .
at concentrations at which either one alone showed only minimal activity. Under these latter conditions the combined effect of chloride and iodide was greater than additive . Cytotoxicity was abolished by deletion of each component of the system, by pretreating the PMN with heat, homogenization or sonication, or by the use of nonopsonized zymosan. These experiments all employed a ratio of effector to target cells of 2.5:1 . A cytotoxic effect was present at a ratio of 1 .25:1 but was not detectable at 0 .5:1 .
Supplements
Chloride ( A cyctotoxic effect of PMN was also demonstrated by loss of oncogenicity of LSTRA target cells for mice . Nearly all animals (22 of 24) receiving 105 control LSTRA cells exposed to the buffer system alone developed tumors and died. In contrast, only 6 of 24 mice receiving cells exposed to the complete cytotoxicity system (PMN, zymosan, 0.04 M chloride, and 10 -5 M iodide as in Table I ) died with tumors (P < 0.05, chi-square test) . Omission of PMN, zymosan, or both halides resulted in tumors and death in six of six, six of six, and five of six animals, respectively .
Involvement of the Peroxidase System . The mechanism of the cytotoxic effect of phagocytosing PMN was initially investigated with the use of specific inhibitors (Table 1 ) . Cytotoxicity was abolished by the heme enzyme inhibitors, azide and cyanide. Catalase caused similar inhibition, an effect which was largely reversed by preheating the enzyme. Since these studies suggested involvement of MPO and H20 2, experiments were performed employing PMN from patients with leukocytic defects including a patient with hereditary MPO deficiency and six patients with defective H 20 2 production (leukocyte G6PD deficiency and CGD) . No significant release of "Cr above controls was observed when PMN from any of these patients were substituted for normal cells (Fig . 1 ) . Attempts were then made to restore cytotoxic activity by adding purified MPO, reagent H 202 or a peroxide generating enzyme system (glucose and glucose oxidase) (Fig.  1, inset) . MPO-deficient PMN had a potent cytotoxic effect in the presence of added MPO (p < 0.001, t test) but remained without activity when H20 2 or glucose oxidase was added. In contrast, PMN from CGD patients remained inactive when MPO was added, but significant cytotoxic activity was restored by Cytotoxicity system using PMN from patients with leukocytic defects. The reaction mixtures were as described for the complete PMN-zymosan-halide systems in Table 1 . Halide concentrations were as follows: chloride system, 0.1 M NaCl ; iodide system, 10' M Nal; and chloride plus iodide system, 0.04 M NaCl and 10 -5 M Nal. either H20 2 (p < 0.01) or the glucose oxidase system (p < 0.001), the latter being more effective. This restoration of activity is consistent with reports of normal or increased H202 production by MPO-deficient PMN (16) and normal secretion of MPO in CGD leukocytes (3, 17) . Discussion These studies demonstrate the ability of human PMN to act as effector cells against mammalian tumor cells in vitro using a relatively low ratio of effector to target cells and two cytotoxicity assays : S 1Cr release and loss of oncogenicity . Cytotoxicity depends on the presence of intact PMN, phagocytosable particles, and a halide cofactor . Studies employing inhibitors and leukocytes from patients with neutrophil dysfunction syndromes clearly implicate MPO and H20 2 in mediating this cytotoxic effect . A mechanism involving the reaction of secreted MPO and H 202 with extracellular halides to form a cytotoxic system is proposed . Since the blood monocyte also contains MPO and forms H202 during phagocytosis (for review see 18), the MPO-mediated cytotoxicity system may also be operative with this cell type .
While the data presented point out the cytotoxic potential of PMN via the MPO-H202-halide system, the effects observed are not target cell specific . In particular there is currently no evidence for increased susceptibility of tumor cells to peroxidase-mediated damage and toxic effects of the isolated peroxidase system on normal mammalian cells have been clearly demonstrated (7, 15, 19) . Neutrophil-mediated cytotoxicity could acquire target cell specificity through the participation of humoral or cellular immune responses to tumor antigens. Immunologically directed neutrophil accumulation might be expected to result from the release of chemotactic lymphokines or the interaction of neoplastic cells and tumor-specific antibody with associated formation of complement-derived chemotactic agents . Attachment of antibody molecules to the tumor cell surface would also provide a mechanism for immunologically specific release of peroxidase system components. While particle ingestion served as the stimulus for MPO and H 202 release in the current study, secretion of enzymes (4, 20) including MPO (4) and metabolic stimulation (17, 21) also occur when neutrophils come in contact with antigen-antibody complexes on a nonphagocytosable membrane surface. Evidence has been presented for in vivo attachment of immunoglobulins to the surface of tumor cells (22) and a report of in vitro killing of antibody-coated malignant cells by human neutrophils has recently appeared (23) . The demonstration of peroxidase-mediated cytotoxicity for mammalian tumor cells using both cell-free systems (7, 9) and intact human PMN raises the possibility that the neutrophil is involved via the peroxidase system in the host defense against neoplastic disease. Summary A cytotoxic effect of human neutrophils on mammalian tumor cells is demonstrated . Cytotoxicity depends on the presence of intact neutrophils, phagocytosable particles, and a halide cofactor and is inhibited by azide, cyanide, and catalase . Neutrophils from patients with myeloperoxidase (MPO) deficiency or defective H202 production are not cytotoxic, but activity is restored by addition of purified MPO or H202 respectively . The findings support a mechanism involving the phagocytosis-induced extracellular release of MPO and H202 and their reaction with a halide cofactor to damage the target cells .
